Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2012
The study hypothesis is that two doses of cold-adapted, live monovalent A/17/mallard/Netherlands/00/95 (H7N3) influenza vaccine will be safe and immunogenic in healthy adults.
Epistemonikos ID: 54a84c0f3b88c91884537a82f1ef3263412879e4
First added on: Nov 24, 2021